Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clara De Simone

Showing results (151-160 of 213) with videos related to

Pageof 22
Sort By:
Gut|November 21, 2013
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression?Franco Scaldaferri, Valentina Petito, Alfredo Papa, et al.
Advances in Therapy|April 23, 2017
The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic PatientsDelia Colombo, Giuseppe Banfi, Nicoletta Cassano, et al.
Expert Opinion on Drug Safety|May 8, 2024
Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatmentGiacomo Caldarola, Lorenzo Maria Pinto, Francesco Bellinato, et al.
European Journal of Dermatology : EJD|October 17, 2018
Alexithymia affects patients with hidradenitis suppurativaAndrea Chiricozzi, Giulia Giovanardi, Dante Raffaele Caposiena Caro, et al.
Clinical and Experimental Dermatology|June 27, 2025
Predictive Factors of Eczematous Eruptions and Candidiasis during anti IL-17 Treatment in Psoriatic Patients: a Multicenter Italian Real-life Experience in Lazio RegionGiacomo Caldarola, Eleonora De Luca, Simone Amato, et al.
Dermatology (Basel, Switzerland)|April 27, 2007
Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of ImmunopathologyPietro Quaglino, Marzia Caproni, Emiliano Antiga, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|March 10, 2015
Psoriasis awareness among Italian patients: results of a nationwide surveyFederico Bardazzi, Paolo Amerio, Giuseppe Amoruso, et al.
Expert Opinion on Biological Therapy|October 11, 2013
Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue?Clara De Simone, Paolo Amerio, Giuseppe Amoruso, et al.
International Journal of Dermatology|March 30, 2026
Superior Clinical and Economic Value of IL-23 Inhibitors Versus Adalimumab Biosimilars in Plaque PsoriasisGennaro Marco Falco, Elena Ippoliti, Niccolò Gori, et al.
The Journal of Dermatological Treatment|April 30, 2013
Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol® gel) in the treatment of scalp psoriasis: results from a study in 885 patientsRosita Saraceno, Germana Camplone, Magda D'Agostino, et al.
Pageof 22

Showing results (151-160 of 213) with videos related to

Sort By:
Pageof 22
Gut|November 21, 2013
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression?Franco Scaldaferri, Valentina Petito, Alfredo Papa, et al.
Advances in Therapy|April 23, 2017
The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic PatientsDelia Colombo, Giuseppe Banfi, Nicoletta Cassano, et al.
Expert Opinion on Drug Safety|May 8, 2024
Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatmentGiacomo Caldarola, Lorenzo Maria Pinto, Francesco Bellinato, et al.
European Journal of Dermatology : EJD|October 17, 2018
Alexithymia affects patients with hidradenitis suppurativaAndrea Chiricozzi, Giulia Giovanardi, Dante Raffaele Caposiena Caro, et al.
Clinical and Experimental Dermatology|June 27, 2025
Predictive Factors of Eczematous Eruptions and Candidiasis during anti IL-17 Treatment in Psoriatic Patients: a Multicenter Italian Real-life Experience in Lazio RegionGiacomo Caldarola, Eleonora De Luca, Simone Amato, et al.
Dermatology (Basel, Switzerland)|April 27, 2007
Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of ImmunopathologyPietro Quaglino, Marzia Caproni, Emiliano Antiga, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|March 10, 2015
Psoriasis awareness among Italian patients: results of a nationwide surveyFederico Bardazzi, Paolo Amerio, Giuseppe Amoruso, et al.
Expert Opinion on Biological Therapy|October 11, 2013
Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue?Clara De Simone, Paolo Amerio, Giuseppe Amoruso, et al.
International Journal of Dermatology|March 30, 2026
Superior Clinical and Economic Value of IL-23 Inhibitors Versus Adalimumab Biosimilars in Plaque PsoriasisGennaro Marco Falco, Elena Ippoliti, Niccolò Gori, et al.
The Journal of Dermatological Treatment|April 30, 2013
Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol® gel) in the treatment of scalp psoriasis: results from a study in 885 patientsRosita Saraceno, Germana Camplone, Magda D'Agostino, et al.
Pageof 22